Actelion acquires generic Flolan from GeneraMedix
This article was originally published in Scrip
Executive Summary
Actelion has acquired a generic formulation of GlaxoSmithKline's Flolan (epoprostenol sodium) from the private generic injectables company GeneraMedix. The formulation is for the intravenous treatment of pulmonary arterial hypertension (PAH).